Jamie Sin Ying Ho: Stopping Anticoagulation After AF Ablation and Rhythm Control
Jamie Sin Ying Ho, Clinical Supervisor (Undergraduate) at University of Cambridge, shared ESC Council on Stroke’s post on LinkedIn:
“An intensely informative debate: should we stop anticoagulation after ablation & rhythm control in AF?
Current CoS chair Prof Renate Schnabel (YES) vs past chair Prof Gregory Lip (NO)
Ocean and Alone AF support discontinuation in pts with low stroke risk, high bleeding risk & no recurrence for high 1 yr
But risk is dynamic, and the burden of monitoring recurrence and new comorbidities falls on clinician and patient
Trials may be underpowered to detect stroke, few events were reported
Open questions: How much monitoring of AF recurrence is enough?
For how long?
ILR vs prolonged Holter?
But what is the AF burden that is clinically relevant?
Beyond stroke: heart failure and cognitive outcomes (e.g. dementia) matter too
A comprehensive view of the patient regarding the co morbidities other etiologies of stroke is essential.”
ESC Council on Stroke shared post on LinkedIn:
“Great Debate ongoing:
Should we stop OAC after Afib ablation?
Yes: prof Renate Schnabel
No: prof Gregory Lip
How do you support?”
Stay updated with Hemostasis Today.
-
Nov 14, 2026, 14:29Satya Prakash: Cell-Free Hemoglobin-Based Oxygen Carriers and Their Clinical Development
-
Nov 14, 2026, 14:24Adela Castro: Distinguishing Antiphospholipid Antibodies From APS in Pregnancy
-
Nov 14, 2026, 14:20Uzima Chirwa: Rethinking Comprehensive Care for Bleeding Disorders in Africa
-
Nov 14, 2026, 14:19Samuele Ferrari: Launching a New Era in Hematopoietic Genome Editing Research
-
Nov 14, 2026, 14:17Stefan Hofer: International Training in Postpartum Hemorrhage Management
-
Nov 14, 2026, 14:14Expanding Global Access to Gene Therapy – WFH
-
Nov 14, 2026, 14:11Cedric Hermans: Advancing Haemophilia Care Through Innovation and Global Access
-
Nov 14, 2026, 14:08Bruno Pougault: Lupus Anticoagulant Testing During DOAC Therapy
-
Nov 14, 2026, 14:08Francinny Alves Kelly: AHA Scientific Sessions 2026 Features Research on CHA₂DS₂-VASc and Transhepatic AF Ablation